CORC

在结果中检索

CORC

浏览/检索结果: 共45条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2022
作者:  He, Libin;  Shen, Xiabo;  Liu, Yiyuan;  Gao, Lu;  Wu, Jiayi
收藏  |  浏览/下载：22/0  |  提交时间：2022/12/23
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang
收藏  |  浏览/下载：18/0  |  提交时间：2022/12/22
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers 期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:  Cao, Jiang-yan;  Qi, Shuang;  Wu, Hong;  Wang, Ao-li;  Liu, Qing-wang
收藏  |  浏览/下载：92/0  |  提交时间：2022/03/28
Application of Noninvasive Imaging to Combined Immune Checkpoint Inhibitors for Breast Cancer: Facts and Future 期刊论文
MOLECULAR IMAGING AND BIOLOGY, 2022, 页码: 16
作者:  Cheng, Zhongquan;  Du, Yang;  Yu, Leyi;  Yuan, Zhu;  Tian, Jie
收藏  |  浏览/下载：43/0  |  提交时间：2022/03/17
YES1amplification confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive cancer 期刊论文
BRITISH JOURNAL OF CANCER, 2020, 页码: 12
作者:  Wang, Lei;  Wang, Quanren;  Xu, Piaopiao;  Fu, Li;  Li, Yun
收藏  |  浏览/下载：15/0  |  提交时间：2020/12/24
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial 期刊论文
CLINICAL CANCER RESEARCH, 2019, 卷号: 25, 期号: 17, 页码: 5212-5220
作者:  Li, Qiao;  Guan, Xiuwen;  Chen, Shanshan;  Yi, Zongbi;  Lan, Bo
收藏  |  浏览/下载：15/0  |  提交时间：2020/07/01
One-Step SH2 Superbinder-Based Approach for Sensitive Analysis of Tyrosine Phosphoproteome 期刊论文
JOURNAL OF PROTEOME RESEARCH, 2019, 卷号: 18, 期号: 4, 页码: 1870-1879
作者:  Li, Yanan;  Yao, Yating;  Wang, Yan;  Wang, Shujuan;  Liu, Xiaoyan
收藏  |  浏览/下载：65/0  |  提交时间：2019/06/20
Correlation between long non-coding RNAs (lncRNAs) H19 expression and trastuzumab resistance in breast cancer 期刊论文
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 卷号: 15, 期号: 4, 页码: 933-940
作者:  Sun, Zhigang;  Zhang, Chi;  Wang, Tiantian;  Shi, Peng;  Tian, Xingsong
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/11
Mechanism of trastuzumab resistance caused by HER-2 mutation in breast carcinomas 期刊论文
2019, 卷号: 11, 页码: 5971-5982
作者:  Kong, Xiangyi;  Zhang, Kai;  Wang, Xiangyu;  Yang, Xue;  Li, Yalun
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
STAT3 activation confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive breast cancer 期刊论文
CANCER SCIENCE, 2018, 卷号: 109, 期号: 10, 页码: 3305-3315
作者:  Wang, Lei;  Wang, Quanren;  Gao, Mingzhao;  Fu, Li;  Li, Yun
收藏  |  浏览/下载：51/0  |  提交时间：2019/01/08

©版权所有 ©2017 CSpace - Powered by CSpace